Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Researchers at the University of Utah have introduced RiskPath, an AI toolkit designed to predict chronic diseases before symptoms appear, as announced in a press release.
ProofPilot has announced a partnership with the Digital Medicine Society to advance digital health in clinical trials, focusing on participant-centered study experiences and tools to prevent opioid use disorder relapse.
Axtria has introduced LUCCID, a GenAI-powered solution to automate the extraction of unstructured clinical data, announced in a press release.
Health Catalyst has announced a strategic partnership with Microsoft to enhance AI adoption in healthcare, leveraging Microsoft Azure and Azure AI Foundry.
Unravel Biosciences has submitted clinical study applications for RVL-001 trials targeting Rett and Pitt Hopkins syndromes to Colombia's INVIMA for priority review.
Persivia has completed a $107 million recapitalization with Aldrich Capital Partners to expand its AI-driven digital health solutions across the U.S.
Fangzhou Inc. is at the forefront of China's AI healthcare initiative as the country issues a digital transformation roadmap for the pharmaceutical industry.
RamSoft and Maverick Medical AI have announced a partnership to integrate AI-powered coding into radiology workflows, improving billing accuracy and operational efficiency.
Veeva Systems has announced Veeva AI, a new initiative to integrate AI into its applications and the Veeva Vault Platform, aiming to automate tasks and boost productivity in the life sciences sector.
Enlil, Inc. has announced significant growth in its AI-driven development traceability platform, enhancing compliance and collaboration in the MedTech sector.
United Imaging Healthcare has released its 2024 annual report, showcasing robust financial performance and significant advancements in AI-powered medical devices.
C the Signs, an AI-led triage platform, has improved early cancer detection rates by 20% across NHS GP practices, while reducing unnecessary urgent referrals by over 61,000 patients, announced in a press release.
House Rx has announced a new AI capability that streamlines the prior authorization process for specialty medications, achieving a 92% first-pass approval rate.
Gestalt Diagnostics has raised $7.5 million in Series A funding to expand its AI-powered PathFlow platform, with the round led by Cowles Ventures and other investors.
Belong.Life has partnered with Equiva to integrate AI mentors into healthcare platforms, aiming to enhance patient support and outcomes.
O'Shaughnessy Ventures has awarded a $100,000 fellowship to AI researcher Miguel Solano to advance projects in drug discovery and clean energy.
Symphony Robotics has appointed Dr. Neil A. Martin as Chief Medical Officer to lead the development of its MRI-steerable micro-robotics for glioblastoma treatment.
Precision for Medicine and PathAI have announced a strategic collaboration to integrate AI-based technologies into clinical trial and biospecimen operations, enhancing biomarker discovery and pathology tools.
Clarius Mobile Health has launched Clarius Prostate AI, an FDA-cleared tool for handheld ultrasound scanners, enabling quick prostate volume assessments.
ApolloMD has announced a partnership with Cleo Health to implement AI technology in emergency medicine, aiming to improve patient care and physician satisfaction.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
